Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: Summary of the NICE guideline

Heart

Volumn 96, Issue 11, 2010, Pages 879-882

  Hill, Jennifer ^a   Treasure, Tom ^b  

^a ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BLEEDING; DEEP VEIN THROMBOSIS; FOOT; HEART DISEASE; HEART SURGERY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; KIDNEY FAILURE; LUNG EMBOLISM; MEDICAL INSTRUMENTATION; PATIENT INFORMATION; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SHORT SURVEY; VENOUS THROMBOEMBOLISM;

GREAT BRITAIN; HOSPITALIZATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMBOLISM; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 77953702320     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.198275     Document Type: Short Survey

References (2)

1. House of Commons Health Select Committee. The prevention of venous thromboembolism in hospitalised patients: second report of session 2004-5, 2005 http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/99/99.pdf.
2. Choudhry NK, Anderson GM, Laupacis A, et al. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ 2006;332:141-5.